FOR IMMEDIATE RELEASE
Media Contact:
Anne Bell
(301) 998-6785
adb@usp.org
As part of the newly expanded role, the senior vice president global external affairs will help lead the organization into its 200th year and bicentennial convention.
Rockville, Md., February 05, 2019 - USP announced today that Anthony (Tony) Lakavage, J.D., senior vice president, global external affairs, will assume the roles of secretary to the USP Convention and secretary to the board of trustees, while continuing his leadership of the USP global external affairs division.
As secretary to the board of trustees, Lakavage will work closely with Susan C. Winckler, R.Ph., J.D., who was recently elected to lead the organization’s 13-member board.
As secretary to the convention, Lakavage will help lead the United States Pharmacopeial Convention, the organization’s governing body in its 200th anniversary year. In this capacity, he will work closely with Dr. Jesse L. Goodman, MD, MPH who was elected convention president for the 2015 – 2020 cycle. Every five years, the Convention’s 450 member organizations meet to elect the next Convention president, the board of trustees and its officers, as well as to help develop the organization’s priorities.
As USP prepares to celebrate its 200th anniversary, we will be showcasing how we will expand upon our legacy of public health impact, as well as how we can accelerate tomorrow’s innovations and help build trust in their quality. With so much to celebrate and anticipate, there could not be a more exciting time to serve as secretary to USP’s governing bodies,” Lakavage said. “I’m also honored to be working with the talented and dedicated individuals who serve on our board, as well as the hundreds of delegates from our member organizations who will help craft USP’s future at the 2020 Convention.”
Lakavage succeeds Susan de Mars, J.D., USP’s former executive vice president, chief legal officer and secretary to the USP Convention, who retired in January after 14 years of service.
“USP is fortunate that Tony can take on this expanded role,” said Dr. Ronald T. Piervincenzi, USP’s CEO. “His leadership has helped USP strengthen its ties and partnerships with our many stakeholders and volunteers. These new responsibilities are a natural extension of this important work.”
Lakavage joined USP in 2015 to lead the newly formed global external affairs division, which includes communications and stakeholder engagement, as well as U.S. and international public policy and regulatory affairs, and the USP Quality Institute. Under Lakavage’s leadership, USP took on many new challenges including establishing the USP Quality Institute, a new research and advocacy initiative developing evidence to support policy decisions related to medicines quality; earning official relations status from the World Health Organization (WHO), becoming a Center of Excellence of the Asia Pacific Economic Cooperation (APEC); establishing the Dietary Supplements Quality Collaborative in the US; launching the global Medicines We Can Trust campaign; and establishing a new brand identity for USP which focusses on the organization’s public health impact.
Prior to joining USP, Lakavage had over 30 years of experience working in the US and internationally in both the life sciences industry and the public sector. Lakavage is a cum laude graduate of Saint Joseph’s University, and a cum laude graduate of the Temple University, Beasley School of Law. He has been admitted to the Bar in the Commonwealth of Pennsylvania and in the State of New Jersey.
About USP
USP is an independent scientific organization that collaborates with the world’s top experts in health and science to develop quality standards for medicines, dietary supplements, and food ingredients. Through our standards, advocacy and education, USP helps increase the availability of quality medicines, supplements and food for billions of people world-wide. For more information about USP, visit www.usp.org